RAB11FIP5

Across TCGA pan-cancer cohorts, RAB11FIP5 Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated RAB11FIP5 data layer compared with 22 for mass-spec protein and 4 for mass-spec protein.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher RAB11FIP5 Mutation is associated with better overall survival. In most high-consensus cancer types, elevated RAB11FIP5 expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

UCEC, LUAD, and BLCA are the cancer types where RAB11FIP5 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	OS	Median	All	1.000	0.656	.008	32	view →
LUAD	OS	Median	II,III,IV	0.250	0.711	.004	21	view →
BLCA	DFS	Median	IV	0.124	0.469	.029	6	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

RAB11FIP5–UCEC (OS)

Open the UCEC breakdown →